Compare American Well Corp (AMWL) vs Linde PLC (LIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Well Corp vs Linde PLC — how do they compare? American Well Corp trades at $9.89 (market cap $165.58M), while Linde PLC trades at $532.24 (market cap $244.95B). The key difference: Linde PLC is far larger — about 1479.3× American Well Corp's market cap, and Linde PLC pays a 1.21% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | LIN | |
|---|---|---|
Market Cap | $165.58M | $244.95B |
Sector | Health | Basic Materials |
52-Week High | $9.91 | $546.64 |
52-Week Low | $3.78 | $389.38 |
Enterprise Value | -$9.66M | $267.30B |
Dividend Yield | — | 1.21% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
Linde (LIN) trades at $529.79, up 0.8% on the day, showing consistent earnings beats with Q1 2026 EPS of $4.33 surpassing estimates. The stock exhibits bullish technical signals with strong support at $521 and resistance at $529. Fundamentally, the company maintains robust profitability with a 20.44% net income margin and 18.49% ROE, though valuation metrics appear elevated with a P/E of 35.13. Recent news highlights sustainability leadership and Q1 earnings strength.
Outlook remains positive with analyst consensus strongly bullish (24 Buy, 4 Hold) and a $560 price target representing 5.7% upside. Key opportunities include sustained margin expansion and disciplined capital allocation returning $1.5B to shareholders. Primary risks include elevated valuation multiples and increasing debt-to-asset ratio reaching 31.63% in 2025, potentially limiting financial flexibility during economic downturns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Well Corp
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →About Linde PLC
Linde is the largest industrial gas supplier in the world, with operations in over 100 countries. The firm's main products are atmospheric gases (including oxygen, nitrogen, and argon) and process gases (including hydrogen, carbon dioxide, and helium), as well as equipment used in industrial gas production. Linde serves a wide variety of end markets, including chemicals, manufacturing, healthcare, and steelmaking. Linde generated approximately $31 billion in revenue and $5 billion in GAAP operating profit in 2021.
Read more on LIN →
